Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Long‐term results of the radiation therapy oncology group study 81‐17

Cancer

Volumn 66, Issue 9, 1990, Pages 1861-1868

  Marcial, Víctor A ^a   Pajak, Thomas F ^b   Mohiuddin, M ^c   Cooper, Jay S ^d   Al Sarraf, M ^e   Mowry, Phyllis A ^f   Curran, Walter ^g   Crissman, John ^h   Rodríguez, Marisol ^a   Vélez‐Garca, Enrique ^a  

^a UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

^b RADIATION THERAPY ONCOLOGY GROUP   (United States)

^c THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^e WAYNE STATE UNIVERSITY   (United States)

^f Fresno Community Hospital and Medical Center   (United States)

^g FOX CHASE CANCER CENTER   (United States)

^h HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; KERATIN;

ARTICLE; CANCER RADIOTHERAPY; FEMALE; HEAD AND NECK CANCER; HISTOCHEMISTRY; HISTOLOGY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMAN; MALE; RADIOTHERAPY;

EID: 0025132144     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19901101)66:9<1861::AID-CNCR2820660902>3.0.CO;2-I     Document Type: Article

References (16)

1. Ninth Annual del Regato Lecture: Optimal multidisciplinary management of head and neck cancer
2. Prognostic factors for loco‐regional control and metastasis and the impact on survival
3. Adjuvant intravenous methotrexate or definitive radiotherapy alone for advanced cancer of the oral cavity, oropharynx supraglottic larynx, or hypopharynx: Concluding report of an RTOG randomized trial on 638 patients
4. Multidrug chemotherapy (vincristine, bleomycin, and methotrexate) and radiotherapy in inoperable carcinomas of the head and neck: Preliminary report of a pilot study of the Radiation Therapy Oncology Group
5. Multidrug chemotherapy (vincristine–bleomycin–methotrexate), followed by radiotherapy in inoperable carcinomas of the head and neck: A pilot study of the Radiation Therapy Oncology Group
6. The adjuvant treatment of inoperable Stage III and IV epidermoid carcinoma of the head and neck with platinum and bleomycin infusions prior to definitive radiotherapy: An RTOG pilot study
7. Final report of the Head and Neck Contracts Program: Adjuvant chemotherapy for advanced head and neck squamous carcinoma
8. Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck; An RTOG study
9. Improved response and survival to combined cisplatin and radiation in non‐keratinizing squamous cell carcinoma of the head and neck: An RTOG study of 114 advanced stage tumor
10. Evaluation of survival data and two new rank order statistics arising in its consideration
11. Non‐parametric estimation from incomplete observation
12. Analysis of survival by tumor response
13. Combined radiation therapy and surgery in the management of advanced head and neck cancer: Final report of study 73‐03 of the Radiation Therapy Oncology Group
14. Skin radio‐sensitization studies using combined cis‐dichlorodiamine‐platinum (II) and radiation
15. Studies on radiosensitization of Escherichia coli cells by cisplatinum complexes
16. Radiation alone versus radiation with weekly low dose cisplatinum in unresectable cancer of the head and neck